1. BEST (biomarkers, endpointS, and other tools);FDA-NIH Biomarker Working Group,2017
2. Principles for codevelopment of an in vitro companion diagnostic Device with a therapeutic product - draft guidance for industry and administration staff;U.S. Food and Drug Administration,2016
3. U.S. Food and Drug Administration. 21st century cures act: qualification of drug development tools: U.S. Department of Health and Human Services.
4. Evolving framework for the co-development of medicinal products with companion diagnostics Status update on the developments in the implementation activities of the MDR/IVDR;Ritzhaupt,2018